H - Cube Pharmaceuticals Private Limited
About H - Cube Pharmaceuticals Private Limited
Data last updated:
H - Cube Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 January 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2022PTC393040.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10,000. It is led by directors Himanshu Sharma and Harpreet Singh.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Joginder Kaur Lamba 4th Floor Office No 404 Kirti Mehal 19 Rajendra Palace, Delhi, India – 110008.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Joginder Kaur Lamba 4th Floor Office No 404 Kirti Mehal 19 Rajendra Palace, Delhi, India – 110008
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of H - Cube Pharmaceuticals Private Limited FY 2025 filings available
Financial Statement Summary of H - Cube Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of H - Cube Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of H - Cube Pharmaceuticals are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of H - Cube Pharmaceuticals Private Limited
H - Cube Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Himanshu Sharma | Director | 29 Jan 2022 | 4 Years 8 Months | Current |
| Harpreet Singh Also directs: Arechar Healthcare LLP, Arechar Nutra Private Limited, Arechar Pharmaceuticals Private Limited and 1 more | Director | 29 Jan 2022 | 4 Years 8 Months | Current |
Charges & Borrowings of H - Cube Pharmaceuticals Private Limited
H - Cube Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at H - Cube Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to H - Cube Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on H - Cube Pharmaceuticals Private Limited
H - Cube Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Harpreet Singh was appointed as Director on 29 Jan 2022.
Credit Ratings, Litigation & Regulatory Alerts for H - Cube Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by H - Cube Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of H - Cube Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of H - Cube Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of H - Cube Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about H - Cube Pharmaceuticals Private Limited
H - Cube Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 January 2022 (4+ years old) and is registered under CIN U33110DL2022PTC393040.
H - Cube Pharmaceuticals has 2 current directors:
- Himanshu Sharma - Director
- Harpreet Singh - Director
The CIN (Corporate Identification Number) of H - Cube Pharmaceuticals is U33110DL2022PTC393040. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
H - Cube Pharmaceuticals was incorporated on 29 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Harpreet Singh was appointed as Director on 29 Jan 2022. Himanshu Sharma was appointed as Director on 29 Jan 2022.
The registered office of H - Cube Pharmaceuticals is at CO Joginder Kaur Lamba 4th Floor Office No 404 Kirti Mehal 19 Rajendra Palace, Delhi, India – 110008.
H - Cube Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10,000.
H - Cube Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
No. H - Cube Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.
H - Cube Pharmaceuticals can be reached at its registered office: CO Joginder Kaur Lamba 4th Floor Office No 404 Kirti Mehal 19 Rajendra Palace, Delhi, India – 110008.